FIELD: medicine.
SUBSTANCE: invention is related to application of therapeutically effective amount of flibanserin or its pharmacologically acceptable acid addition salts to produce a medicine for treating premenstrual disorders. The daily dosage of flibanserin is 0.1 to 400 mg a day.
EFFECT: effective treatment of premenstrual dystrophy, premenstrual mood disorders.
4 cl, 12 ex
| Title | Year | Author | Number |
|---|---|---|---|
| NEW PHARMACEUTICAL COMPOSITIONS FOR SEXUAL DISORDERS | 2005 |
|
RU2445095C2 |
| SOLID DOSAGE FORM | 2004 |
|
RU2377987C2 |
| LAMOTRIGINE-BASED COMPOSITIONS OF PROLONGED RELEASE | 2003 |
|
RU2325163C2 |
| PHARMACEUTICAL COMPOSITION OF PROLONGED ACTION BASED ON CLOZAPINE OF PERORAL INTRODUCTION | 2009 |
|
RU2414903C1 |
| FLUOXETINE ENTEROSOLUBLE GRANULES, COMPOSITION, GELATIN CAPSULE, METHOD OF TREATMENT OF HUMANS AND METHOD OF PREPARING FLUOXETHINE-CONTAINING ENTEROSOLUBLE CAPSULE | 1998 |
|
RU2164405C2 |
| ORAL SOLID DOSAGE FORM AND METHOD OF TREATING | 2011 |
|
RU2480210C1 |
| PERORAL PHARMACEUTICAL MEDICINAL FORMS INCLUDING PROTON PUMP INHIBITOR AND ANTACID SUBSTANCE OR ALGINATE | 1996 |
|
RU2179453C2 |
| HALENIC COMPOSITIONS OF ORGANIC COMPOUNDS | 2005 |
|
RU2384328C2 |
| TABLETS OF CLOZAPINE WITH SUSTAINED RELEASE | 2016 |
|
RU2613192C1 |
| SOLID PHARMACEUTICAL PREPARATION, METHOD OF ITS PREPARATION AND USE | 2021 |
|
RU2809722C1 |
